Meritain Eldorado policies, page 49

Search Meritain Eldorado's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

5,481 public policies Substrate tracks for Meritain Eldorado, by title.

Meritain Eldorado policies
PolicyDetailsCodesSource
[Pharmacy] Opioid Reversal Agents Post Limit PA 1138-J UDR 02-2023 v2 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1138-J · Commercial—Original policy ↗
[Pharmacy] Opioid Reversal Agents Post Limit PA Policy 1138-J UDR 02-2024 v3 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1138-J · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit 2219-M P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2219-M P02-2025 · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit 2219-M P02-2026 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2219-M P02-2026 · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit 4360-M P02-2026 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4360-M · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit FL 4360-M P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug PlanFL 4360-M P02-2025 · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit FL Policy 4360-M UDR 02-2024 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan4360-M · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit Policy 2219-M 02-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2219-M · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit Policy 2219-M 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2219-M · Commercial—Original policy ↗
[Pharmacy] Opioids ER - Step Therapy with MME Limit and Post Limit Policy 2219-M UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2219-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit 2887-M P02-2024 v2_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M P02-2024 v2_R · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit 2887-M P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M P02-2025 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit 2887-M P02-2026 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M P02-2026 v2 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit Policy 2887-M 02-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit Policy 2887-M 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Acute Pain Duration Limit for 19 and Under with MME Limit and Post Limit Policy 2887-M UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2887-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day APAP-ASA-IBU Combo Products - Acute Pain Duration Limit for 19 and Under Policy 2888-E 01-2021 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under 2888-E P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under 2888-E P02-2026 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under Policy 2888-E 02-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under Policy 2888-E 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under Policy 2888-E 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 3-Day Combo Products - Acute Pain Duration Limit for 19 and Under Policy 2888-E UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2888-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with Labeling Limit and Post Limit 2220-M P02-2026 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2220-M P02-2026 v2 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with Labeling Limit and Post Limit 2220-M P02-2026 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2220-M P02-2026 v2 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2024 v2_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M P02-2024 v2_R · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2024 v2_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M P02-2024 v2_R · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2024 v3_R - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M P02-2024 v3_R · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M P02-2025 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit 2221-M P02-2026 v2 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M P02-2026 v2 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit Policy 2221-M 02-2022 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit Policy 2221-M 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit Policy 2221-M UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Acute Pain Duration Limit with MME Limit and Post Limit Policy 2221-M UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan2221-M · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit 1358-E P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit 1358-E P02-2026 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E P02-2026 · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit Policy 1358-E 02-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit Policy 1358-E 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit Policy 1358-E UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - 7-Day Combo Products - Acute Pain Duration Limit Policy 1358-E UDR 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1358-E · Commercial—Original policy ↗
[Pharmacy] Opioids IR - Combo Products Limit 1365-H P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1365-H · Commercial—Original policy ↗
[Pharmacy] Opioids IR - Combo Products Limit 1365-H P02-2025 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1365-H · Commercial—Original policy ↗
[Pharmacy] Opioids IR - Combo Products Limit Policy 1365-H 02-2022 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1365-H · Commercial—Original policy ↗
[Pharmacy] Opioids IR - Combo Products Limit Policy 1365-H 02-2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1365-H · Commercial—Original policy ↗
[Pharmacy] Opioids IR - Combo Products Limit Policy 1365-H 02-2024 - Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1365-H · Commercial—Original policy ↗
[Pharmacy] Opsumit 1647-A SGM P2021 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1647-A · Commercial—Original policy ↗
[Pharmacy] Opsumit 1647-A SGM P2023 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1647-A · Commercial—Original policy ↗
[Pharmacy] Opsumit 1647-A SGM P2024 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1647-A · Commercial—Original policy ↗
[Pharmacy] Opsumit SGM 1647-A P2025 - Specialty Pharmacy Clinical Policy Bulletins Aetna Non-Medicare Prescription Drug Plan1647-A · Commercial—Original policy ↗

Back to Meritain Eldorado

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.